TFOS DEWS II management and therapy report
The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …
based review of current dry eye therapies and management options. Management options …
TFOS DEWS II tear film report
MDP Willcox, P Argüeso, GA Georgiev, JM Holopainen… - The ocular …, 2017 - Elsevier
The members of the Tear Film Subcommittee reviewed the role of the tear film in dry eye
disease (DED). The Subcommittee reviewed biophysical and biochemical aspects of tears …
disease (DED). The Subcommittee reviewed biophysical and biochemical aspects of tears …
Tfos dews ii pathophysiology report
Abstract The TFOS DEWS II Pathophysiology Subcommittee reviewed the mechanisms
involved in the initiation and perpetuation of dry eye disease. Its central mechanism is …
involved in the initiation and perpetuation of dry eye disease. Its central mechanism is …
[HTML][HTML] NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI study
J Tauber, GJ Berdy, DL Wirta, S Krösser, JL Vittitow… - Ophthalmology, 2023 - Elsevier
Objective To evaluate the efficacy and safety of NOV03 (perfluorohexyloctane) ophthalmic
drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction …
drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction …
Tfos dews ii iatrogenic report
Dry eye can be caused by a variety of iatrogenic interventions. The increasing number of
patients looking for eye care or cosmetic procedures involving the eyes, together with a …
patients looking for eye care or cosmetic procedures involving the eyes, together with a …
TFOS DEWS II sex, gender, and hormones report
One of the most compelling features of dry eye disease (DED) is that it occurs more
frequently in women than men. In fact, the female sex is a significant risk factor for the …
frequently in women than men. In fact, the female sex is a significant risk factor for the …
Meibomian gland disease: the role of gland dysfunction in dry eye disease
P Chhadva, R Goldhardt, A Galor - Ophthalmology, 2017 - Elsevier
Topic To discuss the pathology, causes, and ocular surface impact of meibomian gland
disease (MGD), as well as its relationship to dry eye. Clinical Relevance MGD is a common …
disease (MGD), as well as its relationship to dry eye. Clinical Relevance MGD is a common …
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
C Baudouin, EM Messmer, P Aragona… - British Journal of …, 2016 - bjo.bmj.com
Meibomian gland dysfunction (MGD) is the most frequent cause of dry eye disease (DED).
Eyelid inflammation, microbial growth, associated skin disorders as well as potentially …
Eyelid inflammation, microbial growth, associated skin disorders as well as potentially …
Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape
JD Sheppard, KK Nichols - Ophthalmology and Therapy, 2023 - Springer
Meibomian gland dysfunction (MGD) is highly prevalent and is the leading cause of
evaporative dry eye disease (DED). MGD is characterized by a reduction in meibum …
evaporative dry eye disease (DED). MGD is characterized by a reduction in meibum …
[HTML][HTML] NOV03 for signs and symptoms of dry eye disease associated with meibomian gland dysfunction: the randomized phase 3 MOJAVE study
JD Sheppard, F Kurata, AT Epitropoulos… - American Journal of …, 2023 - Elsevier
Purpose To evaluate the efficacy and safety of NOV03 (perfluorohexyloctane) ophthalmic
drop for the treatment of signs and symptoms of dry eye disease (DED) associated with …
drop for the treatment of signs and symptoms of dry eye disease (DED) associated with …